229 related articles for article (PubMed ID: 12487934)
41. The midluteal decline in serum estradiol levels is drastic but not deleterious for implantation after in vitro fertilization and embryo transfer in patients with normal or high responses.
Friedler S; Zimerman A; Schachter M; Raziel A; Strassburger D; Ron El R
Fertil Steril; 2005 Jan; 83(1):54-60. PubMed ID: 15652887
[TBL] [Abstract][Full Text] [Related]
42. Intrauterine injection of human chorionic gonadotropin before embryo transfer significantly improves the implantation and pregnancy rates in in vitro fertilization/intracytoplasmic sperm injection: a prospective randomized study.
Mansour R; Tawab N; Kamal O; El-Faissal Y; Serour A; Aboulghar M; Serour G
Fertil Steril; 2011 Dec; 96(6):1370-1374.e1. PubMed ID: 22047664
[TBL] [Abstract][Full Text] [Related]
43. Unpredictable cases of complicated ovarian hyperstimulation in IVF.
Delvigne A; Vandromme J; Demeestere I; Leroy F
Int J Fertil Womens Med; 1997; 42(4):268-70. PubMed ID: 9309462
[TBL] [Abstract][Full Text] [Related]
44. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
[TBL] [Abstract][Full Text] [Related]
45. Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization.
Kovacs P; Kovats T; Bernard A; Zadori J; Szmatona G; Kaali SG
Fertil Steril; 2008 Dec; 90(6):2133-7. PubMed ID: 18177866
[TBL] [Abstract][Full Text] [Related]
46. Significantly superior response in the right ovary compared with the left ovary after stimulation with follicle-stimulating hormone in a pituitary down-regulation regimen.
Lan KC; Huang FJ; Lin YC; Kung FT; Lan TH; Chang SY
Fertil Steril; 2010 May; 93(7):2269-73. PubMed ID: 19200958
[TBL] [Abstract][Full Text] [Related]
47. Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome.
Ge HS; Huang XF; Zhang W; Zhao JZ; Lin JJ; Zhou W
Fertil Steril; 2008 Jan; 89(1):98-103. PubMed ID: 17524398
[TBL] [Abstract][Full Text] [Related]
48. Can the fall in serum FSH during coasting in IVF/ICSI predict clinical outcomes?
Datta AK; Zosmer A; Tozer A; Sabatini L; Davis C; Al-Shawaf T
Reprod Biomed Online; 2012 May; 24(5):503-10. PubMed ID: 22417663
[TBL] [Abstract][Full Text] [Related]
49. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
Schoolcraft WB; Surrey ES; Minjarez DA; Stevens JM; Gardner DK
Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177
[TBL] [Abstract][Full Text] [Related]
50. [Effects of dyslipidemia on IVF/ICSI pregnancy outcome in patients with polycystic ovary syndrome].
Li X; Ding W; Liu JY; Mao YD; Huang J; Wang W; Ma X
Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):402-408. PubMed ID: 29961283
[No Abstract] [Full Text] [Related]
51. [Dynamic assay of serum inhibin B and estradiol concentrations obtained after gonadotrophin therapy as predictors of ovarian response in vitro fertilization cycle].
Miao MF; Huang HF
Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):114-7. PubMed ID: 16640861
[TBL] [Abstract][Full Text] [Related]
52. Short versus long gonadotropin-releasing hormone analogue suppression protocols for superovulation in patients > or = 40 years old undergoing intracytoplasmic sperm injection.
Sbracia M; Farina A; Poverini R; Morgia F; Schimberni M; Aragona C
Fertil Steril; 2005 Sep; 84(3):644-8. PubMed ID: 16169397
[TBL] [Abstract][Full Text] [Related]
53. [Basic ovarian status and follicular response to superovulation stimulation in an in vitro fertilization and embryo transfer program].
Wei Z; Zhang L; Li M
Zhonghua Fu Chan Ke Za Zhi; 1997 Jan; 32(1):27-30. PubMed ID: 9596867
[TBL] [Abstract][Full Text] [Related]
54. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
[TBL] [Abstract][Full Text] [Related]
55. Correlations between anti-müllerian hormone, inhibin B, and activin A in follicular fluid in IVF/ICSI patients for assessing the maturation and developmental potential of oocytes.
Cupisti S; Dittrich R; Mueller A; Strick R; Stiegler E; Binder H; Beckmann MW; Strissel P
Eur J Med Res; 2007 Dec; 12(12):604-8. PubMed ID: 18024272
[TBL] [Abstract][Full Text] [Related]
56. Serum progesterone at human chorionic gonadotropin injection significantly correlate with female age.
Doldi N; Persico P; De Santis L; Rabellotti E; Papaleo E; Ferrari A
Minerva Ginecol; 2005 Aug; 57(4):477-82. PubMed ID: 16170294
[TBL] [Abstract][Full Text] [Related]
57. Impact of recombinant FSH dose adjustments on ovarian response in the second treatment cycle with IVF or ICSI in "standard" patients treated with 150 IU/day during the first cycle.
Popovic-Todorovic B; Loft A; Ziebe S; Andersen AN
Acta Obstet Gynecol Scand; 2004 Sep; 83(9):842-9. PubMed ID: 15315596
[TBL] [Abstract][Full Text] [Related]
58. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile.
Papanikolaou EG; Tournaye H; Verpoest W; Camus M; Vernaeve V; Van Steirteghem A; Devroey P
Hum Reprod; 2005 Mar; 20(3):636-41. PubMed ID: 15576388
[TBL] [Abstract][Full Text] [Related]
59. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report.
Goswami SK; Das T; Chattopadhyay R; Sawhney V; Kumar J; Chaudhury K; Chakravarty BN; Kabir SN
Hum Reprod; 2004 Sep; 19(9):2031-5. PubMed ID: 15217999
[TBL] [Abstract][Full Text] [Related]
60. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
